Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Treasure Global Inc entered into a $2 million Software Development Agreement with Mestiz Technology Sdn Bhd to build a centralized Power BI business intelligence platform. The platform will integrate data across TGL's lifestyle, digital ecosystem, and fintech business units to enhance management's monitoring of performance and operational risks. The service fee may be paid in cash, common stock, or a combination at the company's discretion.
Ondas Signs $205M M&A Deal with Gate Technologies Ltd. and Bron Technologies sp. z.o.o
Ondas Inc. completed the acquisition of 100% of the share capital of Israel-based Gate Technologies Ltd. and its European affiliate Bron Technologies for $105 million in cash and approximately 10.7 million shares of common stock. The deal includes up to $185 million in contingent earn-out payments and expands Ondas' precision-strike platform with advanced electronic safe-and-arm and fuzing technology.
Value
$205M
Counterparty
Gate Technologies Ltd. and Bron Technologies sp. z.o.o
Onconetix provided a $5.0 million strategic bridge financing facility to Realbotix, LLC, the target of its previously announced pending acquisition. The facility is non-interest bearing and will be automatically cancelled and discharged upon the closing of the all-stock merger. This update supports the working capital needs of Realbotix as the parties work toward completing the transaction.
Angel Oak Financial Strategies Income Term Trust Insider Kevin Parks Buys $12.5K of Stock
Kevin Parks bought 1,000 shares of Angel Oak Financial Strategies Income Term Trust at $12.53 a share, worth $12.5K in total on Sep 14, 2026. Shares held after the trade: 6,667 (+17.6%).
Federal Home Loan Bank of New York Business Update
The Federal Home Loan Bank of New York (FHLBNY) released its August 2026 President's Report, highlighting the announcement of $70.9 million in grants for its 2026 Affordable Housing Program (AHP) Round. The funding will support 47 affordable housing initiatives, creating or preserving over 2,400 homes and driving approximately $850 million in total development activity.
Harvard Apparatus Regenerative Technology Capital Raise of $2.84M
Harvard Apparatus Regenerative Technology closed a private placement of 2,703,727 shares of common stock at $1.05 per share for total proceeds of approximately $2.84 million. The transaction included a $717,911 debt-for-equity conversion by CEO Jerry (Junli) He, who cancelled outstanding bridge promissory notes in exchange for shares at the same offering price.
Cresud Director Fernando Adrian Elsztain Sells $123K of Stock
Fernando Adrian Elsztain, Director, sold 100,000 shares of Cresud Inc at $1.19 to $1.25 a share (average $1.23) in 2 transactions, worth $123K in total between Sep 9, 2026 and Sep 10, 2026. Shares held after the trade: 515,736 (-11.2%).
Park Ohio Holdings Insider James W. Wert Sells $92.4K of Stock
James W. Wert sold 2,000 shares of Park Ohio Holdings Corp at $46.21 a share, worth $92.4K in total on Sep 11, 2026. Shares held after the trade: 91,456 (-2.1%).
Pimco Dynamic Income Strategy Fund Insider Saba Capital Management L.P. Sells $472K of Stock
Saba Capital Management L.P. sold 21,688 shares of Pimco Dynamic Income Strategy Fund at $21.66 to $21.88 a share (average $21.78) in 2 transactions, worth $472K in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 6,351,532 (-0.2%).
NewtekOne, Inc. declared a quarterly cash dividend of $0.19 per share on its common stock and a dividend of $0.53125 per depositary share on its 8.500% Series B Preferred Stock. Both dividends are payable on October 1, 2026, to shareholders of record as of September 24, 2026.
BlackRock ESG Capital Allocation Term Trust Insider Saba Capital Management L.P. Sells $2.29M of Stock
Saba Capital Management L.P. sold 152,342 shares of BlackRock ESG Capital Allocation Term Trust at $14.83 to $15.07 a share (average $15.00) in 2 transactions, worth $2.29M in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 12,765,575 (-0.3%).
Biofrontera received FDA approval for its supplemental New Drug Application (sNDA) for Ameluz in combination with the BF-RhodoLED lamp series to treat superficial basal cell carcinoma. This marks the first and only photodynamic therapy approved in the U.S. for a skin cancer, significantly expanding the addressable market for the company's PDT platform.
“FDA approval of Ameluz for superficial basal cell carcinoma is a defining milestone for Biofrontera. Ameluz is now the first and only photodynamic therapy approved in the United States to treat a skin cancer, which sets our platform apart in medical dermatology and gives dermatologists an effective, non-surgical option for a very common tumor.”
Hermann Luebbert, Chief Executive Officer and Chairman of Biofrontera
Cardiff Oncology entered into a confidential settlement agreement with Nerviano Medical Sciences to resolve litigation in the U.S. District Court for the Southern District of California regarding patent inventorship and license performance. As part of the settlement, the parties amended their 2017 license agreement for onvansertib, updating the royalty structure, exclusivity framework, and granting Nerviano a board observer seat. No monetary payments were made by either party to settle the litigation, which will be dismissed with prejudice.
BioMarin Pharmaceutical Inc. increased its board size from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., as an independent director. Dr. Plenge will receive standard non-employee director fees and was granted restricted stock units (RSUs) valued at $400,000, which vest just prior to the company's next annual meeting.
Ellington Financial Inc. announced a proposed offering of $100 million in 7.375% senior unsecured notes due 2030. These notes are being issued as additional notes under an existing indenture and will be treated as a single class with the $400 million of existing notes previously issued in October 2025. The company intends to use the proceeds for general corporate purposes, including repaying borrowings under repurchase agreements and funding new asset purchases.
HealthStream, Inc. entered into a second amendment to its revolving credit agreement with Truist Bank, extending the maturity date to September 10, 2031. The facility provides for up to $50 million in revolving loans with an option to increase availability by an additional $25 million. Borrowings under the amended agreement remain unsecured and bear interest at rates based on SOFR or a base rate plus an applicable margin.
Baldwin Insurance Group Signs $7.7B M&A Deal with Sequence Holdings and DFO Management
The Baldwin Insurance Group, Inc. has entered into a definitive agreement to be acquired and taken private by Sequence Holdings and DFO Management (the Dell Family Office) for $32.50 per share in cash. The transaction is valued at approximately $7.7 billion, including $3.1 billion of net debt, and represents an 88% premium to the company's unaffected closing price. Upon closing, expected in Q1 2027, Baldwin will become a privately held company with eligible employees retaining a minority equity stake.
XBP Global Holdings entered into securities purchase agreements to raise approximately $6.05 million through a private placement of 2,275,245 shares of common stock. The offering included participation from company insiders, including the CEO, CFO, and affiliates of the Executive Chairman and a Board member, at prices ranging from $2.55 to $2.83 per share. Proceeds are intended for general corporate purposes, and the company has committed to filing a resale registration statement for the shares by September 22, 2026.
Value
$6.05M
Counterparty
Avenue Capital Group, HCI LLC, and other accredited investors
Anixa Biosciences Insider Lewis H. Titterton Jr. Buys $27.3K of Stock
Lewis H. Titterton Jr. bought 10,000 shares of Anixa Biosciences Inc at $2.73 a share, worth $27.3K in total on Sep 10, 2026. Shares held after the trade: 996,967 (+1.0%).
Tower Semiconductor Insider Yoav Chelouche Sells $49.9K of Stock
Yoav Chelouche sold 232 shares of Tower Semiconductor Ltd at $215.06 a share, worth $49.9K in total on Sep 10, 2026. Shares held after the trade: 33,734 (-0.7%).
Or Offer, CEO, sold 118,200 shares of Similarweb Ltd. at $8.05 to $8.06 a share (average $8.06) in 2 transactions, worth $952K in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 4,333,091 (-1.3%).
TransDigm Group Debt Financing Update with Morgan Stanley & Co. LLC
TransDigm Inc., a subsidiary of TransDigm Group, has commenced a cash tender offer to repurchase any and all of its outstanding 6.75% Senior Secured Notes due 2028. Holders tendering by the early deadline of September 25, 2026, will receive $1,008 per $1,000 principal amount, while those tendering later will receive $978. The offer is subject to a refinancing condition, indicating the company likely intends to replace this debt with new financing.
A10 Networks, Inc. has expanded its Board of Directors from five to six members and appointed Mary C. Henry as a new director, effective October 5, 2026. Ms. Henry will serve until the 2027 Annual Meeting of Stockholders and will receive compensation consistent with the company's standard arrangements for non-employee directors.
TransDigm Group's subsidiary, TransDigm Inc., announced a private placement offering of $2.5 billion in senior secured notes. The company intends to use the proceeds to repurchase its outstanding 6.75% Senior Secured Notes due 2028 via a concurrent tender offer and for general corporate purposes.
Immersion Corporation reported Q1 fiscal 2027 total revenues of $294.4 million and GAAP net income of $4.9 million, or $0.17 per diluted share. The results include the consolidated financial information of Barnes & Noble Education, in which Immersion holds a 32.3% stake. The company also declared its sixteenth consecutive quarterly dividend of $0.075 per share.
Term
Q1 2027
“Our fiscal year is off to a strong start. While financial performance can be lumpy, we continue to be focused on executing against strategic initiatives that will drive long-term shareholder value.”
Maia Biotechnology Insider Ramiro Guerrero Buys $49.5K of Stock
Ramiro Guerrero bought 37,595 shares of Maia Biotechnology, Inc. at $1.32 a share, worth $49.5K in total on Sep 10, 2026. Shares held after the trade: 773,296 (+5.1%).
Celularity Inc. has regained compliance with Nasdaq's minimum bid price and minimum market value of listed securities requirements. However, the company remains deficient regarding the timely filing of its periodic reports and is working to complete those filings to fully regain compliance.
Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.52M of Stock
Japan Post Holdings Co. Ltd. sold 13,300 shares of Aflac Inc at $114.21 to $115.16 a share (average $114.32) in 2 transactions, worth $1.52M in total on Sep 10, 2026. Shares held after the trade: 50,612,190 (-0.0%).
Phio Pharmaceuticals has submitted a meeting request and comprehensive briefing package to the FDA to support the next stage of clinical development for its lead candidate, PH-762. The submission follows the completion of a Phase 1b trial and outlines a proposed Phase 2b neoadjuvant study in cutaneous squamous cell carcinoma.
Quantum X, Inc. (formerly Two Hands Corporation) announced that FINRA has approved its corporate name change and a trading symbol change from 'TWOH' to 'QUTX'. The changes became effective in the over-the-counter market at the open of trading on September 14, 2026.